Searched for
ABATACEPT DRUG
Can DRL’s new product launches offset the slowdown in Revlimid sales?Dr Reddy's Laboratories saw a high single-digit revenue increase in Q3, driven by India, emerging, and European markets, despite a muted US...27 Oct, 2025, 05.59 AM IST- Dr Reddy's Laboratories Q2 Results: Profit rises 7% YoY to Rs 1,347 crore, revenue up 10%Dr Reddy's Laboratories Q2 Results: Generic drugmaker Dr Reddy's Labs reported 7% growth in its net profit at Rs 1,347 crore in the Septemb...24 Oct, 2025, 05.34 PM IST
- DRL gears up for biosimilar push, consumer health growth post record FY25Dr Reddy’s stock rose 5.5% in six sessions post-Q4 results, outperforming the BSE Healthcare index. Strong revenue growth, biosimilar launc...20 May, 2025, 05.59 AM IST
- Dr Reddy's shares rally 4% as Nuvama upgrades rating to buyDr. Reddy’s Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate the impact of Re...08 Jan, 2025, 11.33 AM IST
- Stocks in the news: CEAT, HDFC AMC, RBL Bank and Adani PortsAdani Group said that its engagement with financial institutions over a petrochemical project at Mundra in Gujarat was still ongoing. The g...21 Mar, 2023, 07.15 AM IST
- Dr Reddy's Laboratories planning mergers and acquisitions to climb up ladderIndia contributed about a fifth or ₹4,196 crore of the company's overall sales of ₹21,439 crore in 2021-22, but domestic business has clock...24 Jun, 2022, 03.54 PM IST
- How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.29 Sep, 2015, 02.51 AM IST
Load More
